Ignite Creation Date:
2024-05-06 @ 1:06 AM
Last Modification Date:
2024-10-26 @ 10:59 AM
Study NCT ID:
NCT01735253
Status:
COMPLETED
Last Update Posted:
2012-11-28
First Post:
2012-11-24
Brief Title:
Prospective Observatonal Study for Effect of Duodenojejunal Bypass and Gastric Bypass on T2DM Patients
Sponsor:
Inha University Hospital
Organization:
Inha University Hospital
Study Overview
Official Title:
Metabolic Surgery for Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
T2DM
Brief Summary:
Surgical treatment for type 2 diabetes has been taken note especially in less obese or non obese patients In Asian the nuber of less obses or non obese patients with T2DM is greater than that of the obese
We are trying to do a prospective observational study for the evaluation of the effect of duidenojejunal bypass and gastric bypass on the glycemoc control in those patients
The selection criteria are type 2 diabetess 20-60 years old BMI 23-34 or 21-22 with viceral obesity insulin use less than 10 years and the patients understanding the hypothesis of this study risks expecting effects and agreeing this study
We are checking oral GTT insulin level C-peptide level HbA1C etc with some anthropometric measurs preoperatively postoperatively at 3 month and 12 month
We will compare the clinical factors at each time
We are trying to do a prospective observational study for the evaluation of the effect of duidenojejunal bypass and gastric bypass on the glycemoc control in those patients
The selection criteria are type 2 diabetess 20-60 years old BMI 23-34 or 21-22 with viceral obesity insulin use less than 10 years and the patients understanding the hypothesis of this study risks expecting effects and agreeing this study
We are checking oral GTT insulin level C-peptide level HbA1C etc with some anthropometric measurs preoperatively postoperatively at 3 month and 12 month
We will compare the clinical factors at each time
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None